Inherited tubulopathies: molecular mechanisms, pathophysiology, and emerging therapeutic strategies.
文献摘要
Inherited renal tubulopathies comprise a heterogeneous group of rare monogenic disorders characterized by impaired tubular transport, electrolyte imbalance, and disrupted nephron homeostasis. These disorders involve abnormalities in ion channels, transporters, receptors, intracellular trafficking pathways, and cellular organelles, leading to diverse clinical manifestations including salt wasting, metabolic acidosis, abnormal potassium and calcium handling, nephrocalcinosis, and progressive kidney dysfunction. Despite major advances in next-generation sequencing and functional genomics, the molecular basis of a considerable proportion of inherited tubulopathies remains unresolved. This diagnostic gap reflects the complexity of renal tubular biology, including regulatory genomic variants, incomplete genotype-phenotype correlations, and the involvement of previously unrecognized disease mechanisms. A comprehensive understanding of the genetic and molecular pathways underlying hereditary tubulopathies is essential for improving diagnosis, enabling early intervention, and developing targeted therapies. This review summarizes recent advances in the genetics, pathophysiology, and cellular mechanisms of inherited tubulopathies, with particular emphasis on organelle dysfunction, mitochondrial and lysosomal abnormalities, intracellular trafficking defects, and emerging therapeutic strategies. Furthermore, we discuss the potential of precision medicine, gene-based therapies, and kidney organoid platforms to advance the diagnosis and management of these disorders.